A A Strasser1, K Z Tang, M D Tuller, J N Cappella. 1. Transdisciplinary Tobacco Use Research Center, University of Pennsylvania, Philadelphia, Pennsylvania 19104, USA. strasse3@mail.med.upenn.edu
Abstract
BACKGROUND: The Institute of Medicine report on potential reduced exposure products (PREPs) recommends that advertising and labelling be regulated to prevent explicitly or implicitly false or misleading claims. Belief that a product is less harmful may increase use or prevent smoking cessation. OBJECTIVE: To determine the effect of altering advertisement features on smokers' beliefs of the harm exposure from a PREP. METHODS: A Quest advertisement was digitally altered using computer software and presented to participants using web-based television recruitment contracted through a survey company. 500 current smokers completed demographic and smoking history questions, were randomised to view one of three advertisement conditions, then completed eight items assessing their beliefs of the harmfulness of the product. Advertisement conditions included the original, unaltered advertisement; a "red" condition where the cigarette packages were digitally altered to the colour red, implying increased harm potential; and a "no text" condition where all text was removed to reduce explicit product information. Polytomous logistic regression, using "incorrect," "unsure" and "correct" as outcomes, and advertisement type and covariates as predictors, was used for analyses. RESULTS: Participants randomised to the "no text" advertisement were less likely to be incorrect in their beliefs that Quest cigarettes are lower in tar, less addictive, less likely to cause cancer, have fewer chemicals, are healthier and make smoking safer. CONCLUSIONS: Smokers can form false beliefs about the harmfulness of PREP products based on how the PREPs are marketed. Careful examination must be undertaken to provide empirical evidence to better formulate regulatory principles of PREP advertising.
RCT Entities:
BACKGROUND: The Institute of Medicine report on potential reduced exposure products (PREPs) recommends that advertising and labelling be regulated to prevent explicitly or implicitly false or misleading claims. Belief that a product is less harmful may increase use or prevent smoking cessation. OBJECTIVE: To determine the effect of altering advertisement features on smokers' beliefs of the harm exposure from a PREP. METHODS: A Quest advertisement was digitally altered using computer software and presented to participants using web-based television recruitment contracted through a survey company. 500 current smokers completed demographic and smoking history questions, were randomised to view one of three advertisement conditions, then completed eight items assessing their beliefs of the harmfulness of the product. Advertisement conditions included the original, unaltered advertisement; a "red" condition where the cigarette packages were digitally altered to the colour red, implying increased harm potential; and a "no text" condition where all text was removed to reduce explicit product information. Polytomous logistic regression, using "incorrect," "unsure" and "correct" as outcomes, and advertisement type and covariates as predictors, was used for analyses. RESULTS:Participants randomised to the "no text" advertisement were less likely to be incorrect in their beliefs that Quest cigarettes are lower in tar, less addictive, less likely to cause cancer, have fewer chemicals, are healthier and make smoking safer. CONCLUSIONS: Smokers can form false beliefs about the harmfulness of PREP products based on how the PREPs are marketed. Careful examination must be undertaken to provide empirical evidence to better formulate regulatory principles of PREP advertising.
Authors: William L Hamilton; Giulia diStefano Norton; Tammy K Ouellette; Wiliam M Rhodes; Ryan Kling; Gregory N Connolly Journal: Nicotine Tob Res Date: 2004-12 Impact factor: 4.244
Authors: Andrew A Strasser; Richard J O'Connor; Marc E Mooney; E Paul Wileyto Journal: Cancer Epidemiol Biomarkers Prev Date: 2006-12 Impact factor: 4.254
Authors: Kirsten Lochbuehler; Kathy Z Tang; Valentina Souprountchouk; Dana Campetti; Joseph N Cappella; Lynn T Kozlowski; Andrew A Strasser Journal: Drug Alcohol Depend Date: 2016-05-02 Impact factor: 4.492
Authors: Melissa Mercincavage; Megan L Saddleson; Emily Gup; Angela Halstead; Darren Mays; Andrew A Strasser Journal: Drug Alcohol Depend Date: 2017-02-03 Impact factor: 4.492
Authors: Andrew A Strasser; Kathy Z Tang; Daniel Romer; Christopher Jepson; Joseph N Cappella Journal: Am J Prev Med Date: 2012-07 Impact factor: 5.043
Authors: Andrea C Villanti; Julia C West; Darren Mays; Eric C Donny; Joseph N Cappella; Andrew A Strasser Journal: Am J Prev Med Date: 2019-10 Impact factor: 5.043
Authors: Xuewei Chen; Heather Orom; Jennifer L Hay; Erika A Waters; Elizabeth Schofield; Yuelin Li; Marc T Kiviniemi Journal: J Rural Health Date: 2018-11-16 Impact factor: 4.333